JPMorgan strategist Olga Lipikhina says an earnings supercycle will power US stocks higher, signaling long-term bullish sentiment for the S&P 500 and…
Applied Aerospace & Defense's $650 million US IPO highlights strong investor appetite for defense stocks amid elevated geopolitical tensions and military spending.
SpaceX moves closer to an initial public offering, with sources indicating terms may be set this week, marking a milestone for the…
Anthropic's massive IPO filing, expected to rank among the largest tech debuts, underscores surging investor demand for generative AI and could lift…
ERock's $642 million IPO filing aims to capitalize on robust power demand, offering a fresh gauge of investor sentiment toward utility stocks.
The US government’s appeal against a broad tariff refund order sustains trade policy uncertainty, potentially weighing on the dollar and equities as…
Strong corporate earnings reduce recession fears, boosting equity market outlook according to HSBC strategist Max Kettner.
Apotex Health's IPO on the TSX signals a thaw in Canadian public markets, potentially reviving equity issuance and investor sentiment.
Wealthy individuals locked in $1 billion by offloading surging stocks, signaling market-top concerns and prompting reassessment of risk in overheated equities.
Ordinary Americans are largely shut out of hot IPOs like SpaceX; advocates propose retail allocation tranches, direct listings, and SEC reforms to…
SEC Chair proposes loosening gun-jumping rules to simplify IPO marketing and attract more public listings, lifting growth equity markets and investment banking…
Momentum stocks deliver their strongest outperformance ever, signaling a powerful factor trend that analysts say shows no signs of abating.